Depression is a highly prevalent disorder, and researchers still have a lot to learn about its biological underpinnings.

Idorsia Ltd (SIX: IDIA) today announced that André C. Muller, Chief Executive Officer of Idorsia, will present at the J.P. Morgan Healthcare Conference on January 15, 2025, at 15:00 PST / 00:00 CET.

Among the myriad drugmakers laying out their plans for the future at this year’s J.P. Morgan Healthcare Conference, Takeda ...

New research has revealed nearly 300 previously unknown genetic links to depression, in the world’s largest and most diverse genetic study into the condition ever.

New genetic risk factors for depression have been identified across all major global populations for the first time, allowing scientists to predict risk of depression regardless of ethnicity.

The narcolepsy treatment market is projected to grow from USD 5,301.6 million in 2024 to USD 8,718.3 million by 2034, at a ...

An international research team led by the University of Edinburgh and King's College London, with the participation of the Central Institute of Mental Health in Mannheim, has identified new genetic ...

Hundreds of previously unknown genetic hints could one day provide earlier and more tailored treatment for depression, thanks to a major global study.

The largest and most diverse genetic study of depression has identified 300 new genetic risk factors for the condition across ...

New genetic risk factors for depression have been identified across all major global populations for the first time, allowing scientists to predict risk of depression regardless of ethnicity. The ...

Researchers from the University of Edinburgh and King’s College London believe the findings offer new insight into the condition.